Application 021395
- Type
- NDA
- Sponsor
- BOEHRINGER INGELHEIM
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | SPIRIVA | TIOTROPIUM BROMIDE | POWDER;INHALATION | EQ 0.018MG BASE/INH | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0597-0075 | Spiriva | TIOTROPIUM BROMIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0075 | Spiriva | TIOTROPIUM BROMIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | Current |
| 0597-0075 | Spiriva | TIOTROPIUM BROMIDE | Boehringer Ingelheim Pharmaceuticals Inc. | NDA | Current |
| 50090-4248 | Spiriva | TIOTROPIUM BROMIDE | A-S Medication Solutions | NDA | Current |
| 50090-4414 | Spiriva | TIOTROPIUM BROMIDE | A-S Medication Solutions | NDA | Current |
| 50090-4414 | Spiriva | TIOTROPIUM BROMIDE | A-S Medication Solutions | NDA | Current |